Observing diabetes management in liver transplant patients
Adult Patients With Diabetes Mellitus, on Drug Treatment, on the List or Already Undergoing Orthotopic Liver Transplantation: an Observational Study
This study looks at how well diabetes is managed in people with Type 2 diabetes who are waiting for or have received a liver transplant to see how it affects their health and satisfaction with treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna, BO) |
| Trial ID | NCT06816303 on ClinicalTrials.gov |
What this trial studies
This observational study aims to gather data on patients with Type 2 diabetes mellitus who are either on the waiting list for orthotopic liver transplantation or have already undergone the procedure. It will assess metabolic compensation, satisfaction with hypoglycemic therapy, complications related to diabetes or liver disease, and overall survival rates. Participants must have been on the waiting list or post-transplant for at least three months and will provide informed consent to participate.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with Type 2 diabetes who are either on the liver transplant waiting list or have undergone transplantation for at least three months.
Not a fit: Patients who are pregnant or breastfeeding will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of diabetes management in liver transplant patients, leading to improved treatment strategies.
How similar studies have performed: While similar observational studies have been conducted, this specific focus on diabetes management in liver transplant patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * type 2 diabetes mellitus * presence on the list for OLT for at least 3 months or have already been submitted to OLT for at least 3 months * age ≥ 18 years * signature of written informed consent to participate in the observational study, either by the participant or legal guardian Exclusion Criteria: \- Pregnancy or breastfeeding
Where this trial is running
Bologna, BO
- Lucia Brodosi — Bologna, Bo, Italy (Recruiting)
Study contacts
- Principal investigator: Lucia Brodosi — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Lucia Brodosi
- Email: lucia.brodosi2@unibo.it
- Phone: +39 0512143248
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.